Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.695 USD | -0.14% | +1.51% | 0.00% |
05-08 | Earnings Flash (CORZ) CORE SCIENTIFIC Posts Q1 Revenue $179.3M | MT |
05-08 | Core Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 5.28 for the current year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CORZ Stock
- Ratings Core Scientific, Inc.